Updated:
Florence Healthcare
Florence Healthcare launched to digitize the clinical trial investigator site, connecting hospitals and independent clinics to the sponsors and CROs...
Florence Healthcare
Florence Healthcare launched to digitize the clinical trial investigator site, connecting hospitals and independent clinics to the sponsors and CROs running global drug studies. The company's platform manages electronic investigator site files, eRegulatory document exchange, and remote monitoring workflows. Rather than building yet another electronic data capture tool, Florence targeted the administrative binders that sit at every research coordinator's desk. The firm deploys capital through venture-backed equity rounds alongside investors including Insight Partners, who led a $27 million Series C in 2023. The platform sits across Phase I–IV trials and now extends into site feasibility — letting sponsors identify high-performing research locations using historical enrollment data. Major biopharma clients run the system, and the company claims it connects over 10,000 research sites across 45 countries. In 2023, Florence added a remote source document verification module, letting clinical research associates monitor patient charts without travel — a capability that survived the pandemic-era remote monitoring boom and expanded into standard operating procedure at sites that kept the software. The firm also operates a smaller adjacent product for site contract and budget negotiation, bundling it with the core document management suite. The company's structural differentiator is its bottom-up adoption model: rather than selling exclusively to sponsor CTOs, Florence gave away the investigator-side portal for free, building a network where sponsor demand pulled the paying enterprise tier. This created switching costs that generic eBinder tools struggle to match once a site runs dozens of sponsor studies through the same login.
General information
Firm type
null
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Atlanta
Corporate office
Atlanta, GA, United States
Sector focus
Frequently asked questions
How does Florence Healthcare generate revenue?
Florence runs a tiered SaaS model. The investigator site portal is free, creating adoption at the point of care. Sponsors and contract research organizations pay for the enterprise tier, which includes remote monitoring tools, compliance dashboards, and site feasibility analytics. The company's Series C with Insight Partners in 2023 funded expansion into the site selection and budget negotiation modules that attach higher per-seat pricing.
Which clinical trial sponsors use Florence's platform?
The company has publicly named Pfizer, Johnson & Johnson, and several top-20 pharmaceutical firms as enterprise clients. The platform is built for multi-center trials, meaning the same sponsor instance connects to hundreds of investigator sites simultaneously. Florence does not publish a full client list, but the site network's stated scale — over 10,000 connected research sites — implies coverage across the majority of active US trial infrastructure.
Does Florence Healthcare compete with electronic data capture systems?
No — Florence deliberately avoided the crowded EDC market. The platform manages the regulatory binder, not the case report form data. Investigator site files, delegation logs, and training records live in Florence, while patient outcome data lives in the sponsor's EDC. This adjacency makes Florence complementary to tools like Medidata Rave or Oracle Clinical, and the company integrates with several EDC vendors.
What happened to Florence during and after the COVID-19 clinical trial disruption?
The pandemic accelerated adoption dramatically. Regulators issued emergency guidance allowing remote monitoring of trial sites, and Florence's existing remote source document verification tool saw a surge in deployment. The company states that many sites retained remote monitoring capability even after travel restrictions lifted, permanently reducing the volume of on-site visits sponsors schedule per study.
Is Florence Healthcare a public company or planning to go public?
The company has not filed for an IPO or disclosed specific plans. As of its 2023 Series C, Florence remained privately held with venture backing. The clinical trial software sector has produced recent public listings — Veeva Systems, a larger adjacent player, trades publicly — but Florence has not signaled a timeline for a public offering.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: